简体 繁體 日本語 한국어 Bahasa Indonesia Русский Українська English Deutsch Français Español Português Tiếng Việt Türkçe العربية עברית

Syngenta between Basel, Beijing and Washington

Read the PDF edition (2 pages)

Syngenta occupies a special position in this landscape. As Part G recorded, the company was acquired by ChemChina in 2017 and became part of Syngenta Group, a company incorporated in China and owned by the state-controlled Sinochem Holdings, while keeping its global operational headquarters in Basel.1 The planned listing in Shanghai was withdrawn in 2024. Syngenta AG continues to issue bonds in its own name, and its credit rating reflects the expectation of support from its state-owned parent. The company is thus a Basel issuer whose financial fate depends on decisions in Beijing.

Geopolitical tension affects Syngenta from several directions. In the United States, several states have restricted ownership of agricultural land by entities controlled by certain foreign governments. Arkansas ordered a Syngenta subsidiary to divest farmland in 2023.2 Federal legislators have proposed further restrictions on Chinese ownership of agricultural assets and on the participation of Chinese-controlled companies in federal programmes. In Europe, the European Union's foreign subsidies regulation of 2023 allows the Commission to examine whether financial contributions by non-EU states distort competition in the internal market, a regime that could apply to future acquisitions by Syngenta Group or to its participation in public procurement.3

In Switzerland, the Syngenta acquisition fuelled the debate on investment screening, which led to the Federal Council's dispatch on an Investment Screening Act in December 2023. The parliamentary deliberations, which Part G, Chapter V described, had not resulted in a law in force at the time of writing, which left the final scope of the legislation uncertain.4 Any such law would leave the completed Syngenta acquisition untouched while applying to future transactions involving Syngenta Group in Switzerland and to acquisitions of other Basel companies by state-controlled foreign investors. For the scenarios, Syngenta serves as an indicator. Its ability to keep operating freely from Basel in American, European and Chinese markets at the same time shows whether a neutral Swiss headquarters can still function as a bridge between blocs. A forced separation of its businesses along geopolitical lines would point to a fragmented world in which such bridges are no longer tolerated.

Notes

  1. See Part G, Chapter I, section "Syngenta: a Basel company in Chinese ownership", Part G, Chapter II, section "Syngenta: finance under Chinese ownership", and Part G, Chapter V, section "Investment screening and the Syngenta question". To be verified. ↩
  2. On the order of the State of Arkansas of October 2023 requiring Syngenta Seeds to divest agricultural land and on comparable state legislation restricting foreign ownership of farmland, see the announcements of the Arkansas Department of Agriculture and state legislative records. Status to be verified. ↩
  3. Regulation (EU) 2022/2560 of the European Parliament and of the Council of 14 December 2022 on foreign subsidies distorting the internal market, applicable since 12 July 2023, with notification obligations since 12 October 2023. To be verified. ↩
  4. Federal Council, Dispatch on the Federal Act on the Screening of Foreign Investments (Investitionsprüfungsgesetz) of 15 December 2023; state of the parliamentary deliberations in 2025–2026. Status to be verified. ↩

For general information only. This article does not constitute legal or tax advice, does not replace advice on an individual case and creates no lawyer-client relationship. It reflects the legal position as of August 2025.

Setting up or expanding in Switzerland?

Helvetica Register is an information portal. It explains what companies and entrepreneurs from around the world, and in particular from Greater China, Central Asia and the Caucasus, the rest of Asia, the Middle East, Africa and Latin America, need to know about doing business in Switzerland: company law, commercial contracts, licences, banking, tax and residence.

Legal advice in Switzerland is provided by Ressos Legal, a Zurich law practice advising on all areas of Swiss law under the direction of Dr Alexander Ressos. Further information is available at www.ressos.ch.

Your project in Switzerland Speak to Dr Alexander Ressos Company formation, shareholder and commercial agreements, acquisitions, licences, bank accounts, tax and residence permits: I advise on Swiss law and coordinate with your lawyers in your home country, as well as local counsel in other jurisdictions as required.